Dani Bancroft, Author at Labiotech.eu

About

Former Editor, now flitting back and forth as a freelancer. Originally from London and studied Zoology at the University of Reading, UK. Previous work includes having written for The Spark University Newspaper and the Wellcome Trust.

Articles by Dani Bancroft

morphosys genmab janssen cancer immunotherapy

News and Trends 28 Jan 2019

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after the US District Court of Delaware declared three of its cancer immunotherapy patents invalid. MorphoSys began the dispute over Darzalex (daratumumab), Genmab and Janssen’s approved antibody therapy for the blood cancer multiple myeloma. MorphoSys alleged that Darzalex infringed on three of […]

January 28, 2019 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Nov 2016

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

For any drug developer or service provider, cell line development is one of the most challenging phases, especially when subsequent GMP compliance is required. The need to secure good cell lines can, therefore, make all the difference in getting any biological to the market. The Swiss company Celonic has produced CHOvolution™, a cell line kit that allows you to […]

November 19, 2016 - 4 minutesmins - By Dani Bancroft

Sanofi regeneron rheumatoid arthritis salurimab

News and Trends 31 Oct 2016

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a huge success. Now awaiting US FDA and EMA approval, the results from the latest study were presented at the American College of Rheumatology (ACR) annual meeting in San Francisco. Should Sarilumab be approved, this immunotherapy will be used to treat […]

October 31, 2016 - 3 minutesmins - By Dani Bancroft

medimmune astrazeneca cancer pd l1 nsclc trial pd l1

News and Trends 28 Oct 2016

UPDATE: Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type

AstraZeneca’s MedImmune (UK) has published phase Ib study results in The Lancet Oncology. These showed anti-tumour activity of a combination of investigational antibodies in patients with lung cancer. The trial considered patients undergoing treatment with durvalumab and tremelimumab, to see whether the drug combo could act therapeuticaly against locally advanced or metastatic non-small cell lung cancer (NSCLC), irrespective of […]

October 28, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Jul 2016

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

The new Biotech Nodthera will be based in Edinburgh and focus on the discovery and development of novel small molecule candidates to treat inflammation in a range of autoimmune diseases. Founded by Epidarex Capital, it will work alongside Selvita (Poland) in a series of deals worth up to €6.35M. The technology behind Nodthera’s focus is built on […]

July 29, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 28 Jul 2016

World Hepatitis Day 2016: What is the plan for Biotech and Policy Makers?

What is the purpose of the #NoHep campaign? To get rid of the inflammatory Liver viruses which are responsible for killing up to 1.4 million people each year, by 2030. Sometimes also described as the ‘Silent Epidemic’, Hepatitis is the inflammation of the liver, which can be caused by several types of viral infections. Research […]

July 28, 2016 - 2 minutesmins - By Dani Bancroft

biobased economy eu greentech ibbess interview biotechnology electricity plant green startup barcelona

News and Trends 26 Jul 2016

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

Here are 3 events to kickstart your greentech career. As Europe works towards a bioeconomy, challenges like these offer the opportunity to get involved and make Green ideas come to life. Put together by the students from Wageningen University, here are several bioeconomy and sustainability challenges for you to solve before the end of 2016. Maybe this could be a […]

July 26, 2016 - 4 minutesmins - By Dani Bancroft

why lithuania biotech baltic life sciences

News and Trends 26 Jul 2016

What is Lithuania’s role in European Biotech?

Since the days of the Soviet Union, Lithuania has always been considered as a leader in life sciences discoveries in Eastern Europe due to its infrastructure. But what about for Biotech? Nowadays, as a member of the NATO, the European Union, and Eurozone, Lithuania’s life science sector is growing around 20-25% annually; with special focus on […]

July 26, 2016 - 2 minutesmins - By Dani Bancroft

micreos eczema mrsa infection dermatitis antibiotic biotech

News and Trends 25 Jul 2016

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

A new study has shown that on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria on their skin lesions (which include MRSA). Could this the Dutch biotech Micreos therefore have the solution to preventing spread of antibiotic-resistant strains in Eczema patients? Atopic dermatitis (eczema) is an extremely common skin affliction which can cause in painful lesions, […]

July 25, 2016 - 3 minutesmins - By Dani Bancroft

inflarx inflammation fundraising itx 1 biotech antibody

News and Trends 22 Jul 2016

German Biotech raises extra €31M to get first-in-class Antibody through trials

InflaRx, a German-based biopharma, has raised €31M in a series C fundraising. This is to further advance a potentially first-in-class antibody which targets an acute form of self-inflammation. Based in Jena, InflaRx’s founders originally identified C5a (a protein mostly produced in the liver) as a key ‘amplifying factor’ in complement inflammation. This then formed the basis for InflaRx’s candidate IFX-1 – […]

July 22, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Jul 2016

Switzerland discovers Pomegranate ‘Anti-Ageing’ Effect and founds Biotech

Researchers at the École Polytechnique Fédérale de Lausanne (EPFL) have uncovered a molecule in the pomegranate fruit which can prolong the lifespan of animal models. The co-authors who published in Nature went to co-found a biotech Amazentis to develop the wonder molecule into clinical trials. There are many underlying factors to what happens to our bodies as we age. However, […]

July 18, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 15 Jul 2016

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

Cell Medica is a London-based biotech which develops, manufactures and markets personalised cell immunotherapeutics for infectious disease and cancer. It has therefore just acquired a Swiss antibody manufacturing biotech Delenex, to help its progress into the CAR-T field. Update 20/07/16: Cell Medica has also just received EMA Orphan Drug Designation for their CMD-003 candidate. This means it can obtain regulatory and […]

July 15, 2016 - 3 minutesmins - By Dani Bancroft

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Dani Bancroft

About

Articles by Dani Bancroft

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

UPDATE: Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

World Hepatitis Day 2016: What is the plan for Biotech and Policy Makers?

Be part of the European BioEconomy! Here are 3 Dutch GreenTech Events this Year

What is Lithuania’s role in European Biotech?

Eczema could also be caused by Superbugs, so how could this Biotech fight it?

German Biotech raises extra €31M to get first-in-class Antibody through trials

Switzerland discovers Pomegranate ‘Anti-Ageing’ Effect and founds Biotech

UK Biotech buys Swiss Antibodies to accelerate CAR-T Development

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Dani Bancroft

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!